Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer.

del Carmen MG, Micha J, Small L, Street DG, Londhe A, McGowan T.

Gynecol Oncol. 2012 Sep;126(3):369-74. doi: 10.1016/j.ygyno.2012.05.028. Epub 2012 May 30.

PMID:
22659190
2.

A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: a gynecologic oncology group study.

Monk BJ, Blessing JA, Street DG, Muller CY, Burke JJ, Hensley ML.

Gynecol Oncol. 2012 Jan;124(1):48-52. doi: 10.1016/j.ygyno.2011.09.019. Epub 2011 Oct 13.

3.

Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancer.

Gordon AN, Asmar L, Messing MJ, Street DG, Pippitt CH Jr, Bailey CL, Savage J, Young JA.

Gynecol Oncol. 2004 Aug;94(2):533-9.

PMID:
15297200
4.

Neonatal screening in Vancouver for congenital dislocation of the hip.

Lehmann EC, Street DG.

Can Med Assoc J. 1981 Apr 15;124(8):1003-8.

Supplemental Content

Loading ...
Support Center